🇺🇸 FDA
Patent

US 9095539

Anti-adhesin based passive immunoprophylactic

granted A61KA61K2039/505A61K39/0258

Quick answer

US patent 9095539 (Anti-adhesin based passive immunoprophylactic) held by United States of America as represented by the Secretary of the Air Force expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K39/0258, A61P, A61P1/12